{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:52:09Z","timestamp":1722473529370},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1976-4","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T16:11:28Z","timestamp":1450282288000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Epirubicin: a new entry in the list of fetal cardiotoxic drugs? Intrauterine death of one fetus in a twin pregnancy. Case report and review of literature"],"prefix":"10.1186","volume":"15","author":[{"given":"Marialuisa","family":"Framarino-dei-Malatesta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Giancotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Ventriglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Derme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Iannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Tibaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Galoppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Sammartino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Cascialli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,16]]},"reference":[{"key":"1976_CR1","unstructured":"Fecondit\u00e0 in ripresa e calendario riproduttivo posticipato. National Institute of Statistics 2013. http:\/\/noi-italia.istat.it . Accessed 30 June 2015."},{"key":"1976_CR2","unstructured":"I tumori in Italia. National Institute of Health. http:\/\/www.tumori.net . Accessed 18 May 2015."},{"issue":"Suppl 1","key":"1976_CR3","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.3816\/CBC.2003.s.012","volume":"4","author":"VG Kaklamani","year":"2003","unstructured":"Kaklamani VG, Gradishar WJ (2003) Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer? Clin Breast Cancer 4(Suppl 1):S26\u2013S33","journal-title":"Clin Breast Cancer"},{"key":"1976_CR4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejogrb.2013.11.017","volume":"173","author":"M Framarino Dei Malatesta","year":"2014","unstructured":"Framarino Dei Malatesta M, Piccioni MG, Brunelli R, Iannini I, Cascialli G, Sammartino P (2014) Breast cancer during pregnancy: a retrospective study on obstetrical problems and survival. Eur J Obstet Gynecol Reprod Biol 173:48\u201352","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1976_CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1634\/theoncologist.2012-0340","volume":"18","author":"JK Litton","year":"2013","unstructured":"Litton JK, Warneke CL, Hahn KM, Palla SL, Kuerer HM, Perkins GH et al (2013) Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist 18:369\u201376","journal-title":"Oncologist"},{"key":"1976_CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.hlc.2005.06.003","volume":"15","author":"CL Hengel","year":"2006","unstructured":"Hengel CL, Russel PA, Gould PA, Kaye DM (2006) Subacute anthracycline cardiotoxicity. Heart Lung Circ 15:59\u201361","journal-title":"Heart Lung Circ"},{"key":"1976_CR7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2350\/08-03-0435.1","volume":"12","author":"RG Abellar","year":"2009","unstructured":"Abellar RG, Pepperell JR, Greco D, Gundogan F, Kostadinov S, Schwartz J et al (2009) Effects of chemotherapy during pregnancy on the placenta. Pediatric Dev Pathol 12:35\u201341","journal-title":"Pediatric Dev Pathol"},{"key":"1976_CR8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-3-642-20195-0_14","volume":"205","author":"G Koren","year":"2011","unstructured":"Koren G (2011) Fetal risks of maternal pharmacotherapy: identifying signals. Handb Exp Pharmacol 205:285\u201394","journal-title":"Handb Exp Pharmacol"},{"key":"1976_CR9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","volume":"5","author":"E Cardonick","year":"2004","unstructured":"Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5:283\u201391","journal-title":"Lancet Oncol"},{"key":"1976_CR10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajog.2011.07.002","volume":"205","author":"L Nurmohamed","year":"2011","unstructured":"Nurmohamed L, Moretti ME, Schechter T, Einarson A, Johnson D, Lavigne SV et al (2011) Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol 205:533\u2013e1-3","journal-title":"Am J Obstet Gynecol"},{"key":"1976_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000317264","volume":"71","author":"M Leyder","year":"2011","unstructured":"Leyder M, Laubach M, Breugelmans M, Keymolen K, De Greve J, Foulon W (2011) Specific congenital malformations after exposure to cyclophosphamide, epirubicin and 5-fluorouracil during the first trimester of pregnancy. Gynecol Obstet Invest 71:141\u20134","journal-title":"Gynecol Obstet Invest"},{"issue":"2 Suppl","key":"1976_CR12","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1177\/03946320120250S201","volume":"25","author":"M Berretta","year":"2012","unstructured":"Berretta M, Di Francia R, Lleshi A, De Paoli P, Li Volti G, Bearz A et al (2012) Antiblastic treatment, for solid tumors, during pregnancy: a crucial decision. Int J Immunopathol Pharmacol 25(2 Suppl):1S\u201319S","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1976_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00404-012-2287-5","volume":"286","author":"E-S Abdel-Hady","year":"2012","unstructured":"Abdel-Hady E-S, Hemida RA, Gamal A, El-Zafarany M, Toson E, El-Bayoumi MA (2012) Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy. Arch Gynecol Obstet 286:283\u20136","journal-title":"Arch Gynecol Obstet"},{"key":"1976_CR14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(11)61092-1","volume":"379","author":"F Amant","year":"2012","unstructured":"Amant F, Loibl S, Neven P, Van Calsteren K (2012) Breast cancer in pregnancy. Lancet 379:570\u20139","journal-title":"Lancet"},{"key":"1976_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/OGX.0b013e318224e877","volume":"66","author":"EM Ko","year":"2011","unstructured":"Ko EM, Van Le L (2011) Chemotherapy for gynecologic cancers occurring during pregnancy. Obstet Gynecol Surv 66:291\u20138","journal-title":"Obstet Gynecol Surv"},{"key":"1976_CR16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","volume":"28","author":"K Calsteren Van","year":"2010","unstructured":"Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W et al (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28:683\u20139","journal-title":"J Clin Oncol"},{"key":"1976_CR17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1701-2163(15)30999-3","volume":"35","author":"G Koren","year":"2013","unstructured":"Koren G, Karey N, Gagnon R, Marxell C, Nulman I, Senikas V (2013) Cancer chemotherapy and pregnancy. J Obstet Gynaecol Can 35:263\u201380","journal-title":"J Obstet Gynaecol Can"},{"key":"1976_CR18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1200\/JCO.1999.17.3.855","volume":"17","author":"DL Berry","year":"1999","unstructured":"Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE et al (1999) Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 17:855\u201361","journal-title":"J Clin Oncol"},{"key":"1976_CR19","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2266::AID-CNCR14>3.0.CO;2-7","volume":"86","author":"PL Giacalone","year":"1999","unstructured":"Giacalone PL, Laffargue F, B\u00e9nos P (1999) Chemotherapy for breast carcinoma during pregnancy: A French national survey. Cancer 86:2266\u201372","journal-title":"Cancer"},{"key":"1976_CR20","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1590\/S0100-879X2001001200007","volume":"34","author":"RM Peres","year":"2001","unstructured":"Peres RM, Sanseverino MT, Guimar\u00e3es JL, Coser V, Giuliani L, Moreira RK et al (2001) Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res 34:1551\u20139","journal-title":"Braz J Med Biol Res"},{"key":"1976_CR21","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/cncr.22081","volume":"107","author":"KM Hahn","year":"2006","unstructured":"Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M et al (2006) Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107:1219\u201326","journal-title":"Cancer"},{"key":"1976_CR22","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1200\/JCO.2005.03.038","volume":"23","author":"AE Ring","year":"2005","unstructured":"Ring AE, Shannon C, Galani E, Ellis PA (2005) Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol 23:4192\u20137","journal-title":"J Clin Oncol"},{"key":"1976_CR23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cncr.21610","volume":"106","author":"S Loibl","year":"2006","unstructured":"Loibl S, von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B et al (2006) Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 106:237\u201346","journal-title":"Cancer"},{"key":"1976_CR24","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.ejca.2010.09.010","volume":"46","author":"F Amant","year":"2010","unstructured":"Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L et al (2010) Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer 46:3158\u201368","journal-title":"Eur J Cancer"},{"key":"1976_CR25","unstructured":"Pregnancy and Breast Cancer. Royal College of Obstetricians and Gynaecologists. https:\/\/www.rcog.org.uk\/guidelines ."},{"key":"1976_CR26","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1200\/JCO.2007.14.9401","volume":"26","author":"L Gianni","year":"2008","unstructured":"Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB (2008) Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol 26:3777\u201384","journal-title":"J Clin Oncol"},{"key":"1976_CR27","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.ijcard.2014.07.149","volume":"176","author":"S Patan\u00e8","year":"2014","unstructured":"Patan\u00e8 S (2014) Cardiotoxicity: anthracyclines and long term cancer survivors. Int J Cardiol 176:1326\u20138","journal-title":"Int J Cardiol"},{"key":"1976_CR28","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-07-1649","volume":"67","author":"YL Lyu","year":"2007","unstructured":"Lyu YL, Kerrigan JE, Lin CP, Azarova AM, Tsai YC, Ban Y et al (2007) Topoisomerase 11beta mediated DNAdouble-strand breaks:implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res 67:8839\u201346","journal-title":"Cancer Res"},{"key":"1976_CR29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1378\/chest.14-0460","volume":"146","author":"D Nikitovic","year":"2014","unstructured":"Nikitovic D, Juranek I, Wilks MF, Tzardi M, Tsatsakis A, Tzanakakis GN (2014) Anthracycline-dependent cardiotoxicity and extracellular matrix remodeling. Chest 146:1123\u201330","journal-title":"Chest"},{"key":"1976_CR30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1113\/jphysiol.2002.036509","volume":"548","author":"S Siedner","year":"2003","unstructured":"Siedner S, Kr\u00fcger M, Schroeter M, Metzler D, Roell W, Fleischmann BK et al (2003) Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Physiol 548:493\u2013505","journal-title":"J Physiol"},{"key":"1976_CR31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1933719110379650","volume":"18","author":"K Calsteren Van","year":"2011","unstructured":"Van Calsteren K, Verbesselt R, Van Bree R, Heyns L, de Bruijn E, de Hoon J et al (2011) Substantialvariation in transplacental transfer of chemotherapeutic agents in a mouse model. Reprod Sci 18:57\u201363","journal-title":"Reprod Sci"},{"key":"1976_CR32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ygyno.2010.08.019","volume":"119","author":"K Calsteren Van","year":"2010","unstructured":"Van Calsteren K, Verbesselt R, Beijnen J, Devlieger R, De Catte L, Chai DC et al (2010) Transplacental transfer of anthracyclines, vinblastine, and hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol 119:594\u2013600","journal-title":"Gynecol Oncol"},{"key":"1976_CR33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1124\/jpet.113.205419","volume":"346","author":"MM Gziri","year":"2013","unstructured":"Gziri MM, Pokreisz P, De Voz R, Verbeken E, Debi\u00e8ve F, Mertens L et al (2013) Fetal rat hearts do not display acute cardiotoxicity in response to maternal doxorubicin treatment. J Pharmacol Exp Ther 346:362\u20139","journal-title":"J Pharmacol Exp Ther"},{"key":"1976_CR34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1517\/17425255.3.6.819","volume":"3","author":"J Behravan","year":"2007","unstructured":"Behravan J, Piquette-Miller M (2007) At Drug transport across the placenta, role of the ABC drug efflux transporters. Expert Opin Drug Metab Toxicol 3:819\u201330","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1976_CR35","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/1061186X.2012.716847","volume":"20","author":"F Staud","year":"2012","unstructured":"Staud F, Cerveny L, Ceckova M (2012) Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure. J Drug Target 20:736\u201363","journal-title":"J Drug Target"},{"key":"1976_CR36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","volume":"43","author":"MR Syme","year":"2004","unstructured":"Syme MR, Paxton JW, Keelan JA (2004) Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 43:487\u2013514","journal-title":"Clin Pharmacokinet"},{"key":"1976_CR37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdh009","volume":"15","author":"N Germann","year":"2004","unstructured":"Germann N, Goffinet F, Goldwasser F (2004) Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 15:146\u201350","journal-title":"Ann Oncol"},{"key":"1976_CR38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000184745","volume":"32","author":"AK Baumg\u00e4rtner","year":"2009","unstructured":"Baumg\u00e4rtner AK, Oberhoffer R, Jacobs VR, Ostermayer E, Menzel H, Voigt M et al (2009) Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML. Onkologie 32:40\u20133","journal-title":"Onkologie"},{"key":"1976_CR39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1067\/mob.2000.105964","volume":"183","author":"C Achtari","year":"2000","unstructured":"Achtari C, Hohlfeld P (2000) Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obster Gynecol 183:511\u20132","journal-title":"Am J Obster Gynecol"},{"key":"1976_CR40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1469-0705.2001.00373.x","volume":"18","author":"M Meyer-Wittkopf","year":"2001","unstructured":"Meyer-Wittkopf M, Barth H, Emons G, Schmidt S (2001) Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol 18:62\u20136","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1976_CR41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/14767058.2011.557107","volume":"25","author":"E Parodi","year":"2012","unstructured":"Parodi E, Alluto A, Moggio G, Liberale V, Frigerio M, Sismondi P (2012) Transient ventricular hypocinesia after in utero anthracyclines exposure: a case report and review of the literature. J Matern Fetal Neonatal Med 25:189\u201392","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1976_CR42","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/annonc\/mdn396","volume":"19","author":"HA Azim","year":"2008","unstructured":"Azim HA, Peccatori FA, Scarfone G, Acaia B, Rossi P, Cascio R et al (2008) Anthracyclines for gestational breast cancer: course and outcome of pregnancy. Ann Oncol 19:1511\u20132","journal-title":"Ann Oncol"},{"key":"1976_CR43","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/AOG.0b013e31826c32d9","volume":"120","author":"E Cardonick","year":"2012","unstructured":"Cardonick E, Gylmandiar D, Somer RA (2012) Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol 120:1267\u201372","journal-title":"Obstet Gynecol"},{"key":"1976_CR44","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1600-0412.2012.01524.x","volume":"91","author":"MM Gziri","year":"2012","unstructured":"Gziri MM, Debi\u00e8ve F, De Catte L, Mertens L, Barrea C, Van Calsteren K et al (2012) Chemotherapy during pregnancy: Effects of anthracyclines on fetal and maternal cardiac function. Acta Obstet Gynecol Scand 91:1465\u20138","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1976_CR45","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1124\/dmd.106.011387","volume":"34","author":"MJ Zaya","year":"2006","unstructured":"Zaya MJ, Hines RN, Stevens JC (2006) Epirubicin glucuronidation and UGT2B7 developmental expression. Drug Metab Dispos 34:2097\u2013101","journal-title":"Drug Metab Dispos"},{"key":"1976_CR46","first-page":"1705","volume":"27","author":"B Bodner-Adler","year":"2007","unstructured":"Bodner-Adler B, Bodner K, Zeisler H (2007) Breast cancer diagnosed during pregnancy. Anticancer Res 27:1705\u20137","journal-title":"Anticancer Res"},{"key":"1976_CR47","first-page":"5225","volume":"23","author":"A Gadducci","year":"2003","unstructured":"Gadducci A, Cosio S, Fanucchi A, Nardini V, Roncella M, Conte PF et al (2003) Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res 23:5225\u20139","journal-title":"Anticancer Res"},{"key":"1976_CR48","first-page":"261","volume":"25","author":"PV Ginopoulos","year":"2004","unstructured":"Ginopoulos PV, Michail GD, Kourounis GS (2004) Pregnancy associated breast cancer: a case report. Eur J Gynaecol Oncol 25:261\u20133","journal-title":"Eur J Gynaecol Oncol"},{"key":"1976_CR49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-008-0159-2","volume":"115","author":"FA Peccatori","year":"2009","unstructured":"Peccatori FA, Azim HA Jr, Scarfone G, Gadducci A, Bonazzi C, Gentilini O et al (2009) Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat 115:591\u20134","journal-title":"Breast Cancer Res Treat"},{"key":"1976_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/839656","volume":"2012","author":"JL Morrison","year":"2012","unstructured":"Morrison JL, Botting KJ, Soo PS, McGillick EV, Hiscock J, Zhang S et al (2012) Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses? J Pregnancy 2012:1\u201315","journal-title":"J Pregnancy"},{"key":"1976_CR51","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/annonc\/mdi152","volume":"16","author":"S Kilickap","year":"2005","unstructured":"Kilickap S, Barista I, Akgul E, Aytemir K, Aksoyek S, Aksoy S et al (2005) cTnT can be a useful marker for early detection of anthracycline cardiotoxicity. Ann Oncol 16:798\u2013804","journal-title":"Ann Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1976-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T21:47:54Z","timestamp":1498254474000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2407\/15\/951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1976"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1976-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"951"}}